Exact Mass: 563.3359
Exact Mass Matches: 563.3359
Found 362 metabolites which its exact mass value is equals to given mass value 563.3359
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Fosinopril
Fosinopril is a phosphinic acid-containing ester prodrug that belongs to the angiotensin-converting enzyme (ACE) inhibitor class of medications. It is rapidly hydrolyzed to fosinoprilat, its principle active metabolite. Fosinoprilat inhibits ACE, the enzyme responsible for the conversion of angiotensin I (ATI) to angiotensin II (ATII). ATII regulates blood pressure and is a key component of the renin-angiotensin-aldosterone system (RAAS). Fosinopril may be used to treat mild to moderate hypertension, as an adjunct in the treatment of congestive heart failure, and to slow the rate of progression of renal disease in hypertensive individuals with diabetes mellitus and microalbuminuria or overt nephropathy. C - Cardiovascular system > C09 - Agents acting on the renin-angiotensin system > C09A - Ace inhibitors, plain > C09AA - Ace inhibitors, plain D004791 - Enzyme Inhibitors > D011480 - Protease Inhibitors > D000806 - Angiotensin-Converting Enzyme Inhibitors D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents CONFIDENCE standard compound; EAWAG_UCHEM_ID 3324
Dihydroergocornine
D018377 - Neurotransmitter Agents > D015259 - Dopamine Agents > D018491 - Dopamine Agonists
Fosenopril
Phe Ile Arg Glu
Phe Glu Ile Arg
Asn Arg Phe Lys
fosinopril
C - Cardiovascular system > C09 - Agents acting on the renin-angiotensin system > C09A - Ace inhibitors, plain > C09AA - Ace inhibitors, plain D004791 - Enzyme Inhibitors > D011480 - Protease Inhibitors > D000806 - Angiotensin-Converting Enzyme Inhibitors D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents CONFIDENCE standard compound; INTERNAL_ID 2247
Cys Lys Lys Trp
Cys Lys Trp Lys
Cys Trp Lys Lys
Glu Phe Ile Arg
Glu Phe Leu Arg
Glu Phe Arg Ile
Glu Phe Arg Leu
Glu Ile Phe Arg
Glu Ile Arg Phe
Glu Leu Phe Arg
Glu Leu Arg Phe
Glu Arg Phe Ile
Glu Arg Phe Leu
Glu Arg Ile Phe
Glu Arg Leu Phe
Phe Glu Leu Arg
Phe Glu Arg Ile
Phe Glu Arg Leu
Phe Ile Glu Arg
Phe Ile Val Trp
Phe Ile Trp Val
Phe Lys Asn Arg
Phe Lys Arg Asn
Phe Leu Glu Arg
Phe Leu Arg Glu
Phe Leu Val Trp
Phe Leu Trp Val
Phe Asn Lys Arg
Phe Asn Arg Lys
Phe Arg Glu Ile
Phe Arg Glu Leu
Phe Arg Ile Glu
Phe Arg Lys Asn
Phe Arg Leu Glu
Phe Arg Asn Lys
Phe Val Ile Trp
Phe Val Leu Trp
Phe Val Trp Ile
Phe Val Trp Leu
Phe Trp Ile Val
Phe Trp Leu Val
Phe Trp Val Ile
Phe Trp Val Leu
Ile Glu Phe Arg
Ile Glu Arg Phe
Ile Phe Glu Arg
Ile Phe Arg Glu
Ile Phe Val Trp
Ile Phe Trp Val
Ile Ile Arg Tyr
Ile Ile Tyr Arg
Ile Leu Arg Tyr
Ile Leu Tyr Arg
Ile Arg Glu Phe
Ile Arg Phe Glu
Ile Arg Ile Tyr
Ile Arg Leu Tyr
Ile Arg Tyr Ile
Ile Arg Tyr Leu
Ile Val Phe Trp
Ile Val Trp Phe
Ile Trp Phe Val
Ile Trp Val Phe
Ile Tyr Ile Arg
Ile Tyr Leu Arg
Ile Tyr Arg Ile
Ile Tyr Arg Leu
Lys Cys Lys Trp
Lys Cys Trp Lys
Lys Phe Asn Arg
Lys Phe Arg Asn
Lys Lys Cys Trp
Lys Lys Trp Cys
Lys Asn Phe Arg
Lys Asn Arg Phe
Lys Arg Phe Asn
Lys Arg Asn Phe
Lys Trp Cys Lys
Lys Trp Lys Cys
Leu Glu Phe Arg
Leu Glu Arg Phe
Leu Phe Glu Arg
Leu Phe Arg Glu
Leu Phe Val Trp
Leu Phe Trp Val
Leu Ile Arg Tyr
Leu Ile Tyr Arg
Leu Leu Arg Tyr
Leu Leu Tyr Arg
Leu Arg Glu Phe
Leu Arg Phe Glu
Leu Arg Ile Tyr
Leu Arg Leu Tyr
Leu Arg Tyr Ile
Leu Arg Tyr Leu
Leu Val Phe Trp
Leu Val Trp Phe
Leu Trp Phe Val
Leu Trp Val Phe
Leu Tyr Ile Arg
Leu Tyr Leu Arg
Leu Tyr Arg Ile
Leu Tyr Arg Leu
Asn Phe Lys Arg
Asn Phe Arg Lys
Asn Lys Phe Arg
Asn Lys Arg Phe
Asn Arg Lys Phe
Arg Glu Phe Ile
Arg Glu Phe Leu
Arg Glu Ile Phe
Arg Glu Leu Phe
Arg Phe Glu Ile
Arg Phe Glu Leu
Arg Phe Ile Glu
Arg Phe Lys Asn
Arg Phe Leu Glu
Arg Phe Asn Lys
Arg Ile Glu Phe
Arg Ile Phe Glu
Arg Ile Ile Tyr
Arg Ile Leu Tyr
Arg Ile Tyr Ile
Arg Ile Tyr Leu
Arg Lys Phe Asn
Arg Lys Asn Phe
Arg Leu Glu Phe
Arg Leu Phe Glu
Arg Leu Ile Tyr
Arg Leu Leu Tyr
Arg Leu Tyr Ile
Arg Leu Tyr Leu
Arg Asn Phe Lys
Arg Asn Lys Phe
Arg Tyr Ile Ile
Arg Tyr Ile Leu
Arg Tyr Leu Ile
Arg Tyr Leu Leu
Val Phe Ile Trp
Val Phe Leu Trp
Val Phe Trp Ile
Val Phe Trp Leu
Val Ile Phe Trp
Val Ile Trp Phe
Val Leu Phe Trp
Val Leu Trp Phe
Val Trp Phe Ile
Val Trp Phe Leu
Val Trp Ile Phe
Val Trp Leu Phe
Trp Cys Lys Lys
Trp Phe Ile Val
Trp Phe Leu Val
Trp Phe Val Ile
Trp Phe Val Leu
Trp Ile Phe Val
Trp Ile Val Phe
Trp Lys Cys Lys
Trp Lys Lys Cys
Trp Leu Phe Val
Trp Leu Val Phe
Trp Val Phe Ile
Trp Val Phe Leu
Trp Val Ile Phe
Trp Val Leu Phe
Tyr Ile Ile Arg
Tyr Ile Leu Arg
Tyr Ile Arg Ile
Tyr Ile Arg Leu
Tyr Leu Ile Arg
Tyr Leu Leu Arg
Tyr Leu Arg Ile
Tyr Leu Arg Leu
Tyr Arg Ile Ile
Tyr Arg Ile Leu
Tyr Arg Leu Ile
Tyr Arg Leu Leu
PC(18:1/2:0)
PC(18:1/2:0)[U]
PC(2:0/18:1)
Dihydroergocornine
C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C72900 - Adrenergic Antagonist D018377 - Neurotransmitter Agents > D015259 - Dopamine Agents > D018491 - Dopamine Agonists Ergocornine in which a single bond replaces the double bond between positions 9 and 10. C78272 - Agent Affecting Nervous System > C66884 - Dopamine Agonist
N-(2-aminophenyl)-4-[[[(8R,9S)-6-[(2R)-1-hydroxypropan-2-yl]-8-methyl-5-oxo-10-oxa-1,6,13,14-tetrazabicyclo[10.2.1]pentadeca-12(15),13-dien-9-yl]methyl-methylamino]methyl]benzamide
N-(2-aminophenyl)-4-[[[(8R,9S)-6-[(2R)-1-hydroxypropan-2-yl]-8-methyl-5-oxo-10-oxa-1,6,14,15-tetrazabicyclo[10.3.0]pentadeca-12,14-dien-9-yl]methyl-methylamino]methyl]benzamide
N-(2-aminophenyl)-4-[[[(8S,9R)-6-[(2S)-1-hydroxypropan-2-yl]-8-methyl-5-oxo-10-oxa-1,6,13,14-tetrazabicyclo[10.2.1]pentadeca-12(15),13-dien-9-yl]methyl-methylamino]methyl]benzamide
N-(2-aminophenyl)-4-[[[(8R,9R)-6-[(2S)-1-hydroxypropan-2-yl]-8-methyl-5-oxo-10-oxa-1,6,14,15-tetrazabicyclo[10.3.0]pentadeca-12,14-dien-9-yl]methyl-methylamino]methyl]benzamide
N-(2-aminophenyl)-4-[[[(8S,9S)-6-[(2S)-1-hydroxypropan-2-yl]-8-methyl-5-oxo-10-oxa-1,6,14,15-tetrazabicyclo[10.3.0]pentadeca-12,14-dien-9-yl]methyl-methylamino]methyl]benzamide
N-(2-aminophenyl)-4-[[[(8S,9S)-6-[(2S)-1-hydroxypropan-2-yl]-8-methyl-5-oxo-10-oxa-1,6,13,14-tetrazabicyclo[10.2.1]pentadeca-12(15),13-dien-9-yl]methyl-methylamino]methyl]benzamide
(1S)-N1-cyclopentyl-N2-(4-fluorophenyl)-1-(hydroxymethyl)-7-methoxy-9-methylspiro[1,3-dihydropyrido[3,4-b]indole-4,4-piperidine]-1,2-dicarboxamide
N-(2-aminophenyl)-4-[[[(8S,9S)-6-[(2R)-1-hydroxypropan-2-yl]-8-methyl-5-oxo-10-oxa-1,6,13,14-tetrazabicyclo[10.2.1]pentadeca-12(15),13-dien-9-yl]methyl-methylamino]methyl]benzamide
N-(2-aminophenyl)-4-[[[(8S,9R)-6-[(2R)-1-hydroxypropan-2-yl]-8-methyl-5-oxo-10-oxa-1,6,13,14-tetrazabicyclo[10.2.1]pentadeca-12(15),13-dien-9-yl]methyl-methylamino]methyl]benzamide
N-(2-aminophenyl)-4-[[[(8S,9R)-6-[(2R)-1-hydroxypropan-2-yl]-8-methyl-5-oxo-10-oxa-1,6,14,15-tetrazabicyclo[10.3.0]pentadeca-12,14-dien-9-yl]methyl-methylamino]methyl]benzamide
N-(2-aminophenyl)-4-[[[(8R,9R)-6-[(2R)-1-hydroxypropan-2-yl]-8-methyl-5-oxo-10-oxa-1,6,14,15-tetrazabicyclo[10.3.0]pentadeca-12,14-dien-9-yl]methyl-methylamino]methyl]benzamide
N-(2-aminophenyl)-4-[[[(8R,9S)-6-[(2S)-1-hydroxypropan-2-yl]-8-methyl-5-oxo-10-oxa-1,6,14,15-tetrazabicyclo[10.3.0]pentadeca-12,14-dien-9-yl]methyl-methylamino]methyl]benzamide
N-(2-aminophenyl)-4-[[[(8S,9S)-6-[(2R)-1-hydroxypropan-2-yl]-8-methyl-5-oxo-10-oxa-1,6,14,15-tetrazabicyclo[10.3.0]pentadeca-12,14-dien-9-yl]methyl-methylamino]methyl]benzamide
N-(2-aminophenyl)-4-[[[(8R,9R)-6-[(2R)-1-hydroxypropan-2-yl]-8-methyl-5-oxo-10-oxa-1,6,13,14-tetrazabicyclo[10.2.1]pentadeca-12(15),13-dien-9-yl]methyl-methylamino]methyl]benzamide
N-(2-aminophenyl)-4-[[[(8R,9S)-6-[(2S)-1-hydroxypropan-2-yl]-8-methyl-5-oxo-10-oxa-1,6,13,14-tetrazabicyclo[10.2.1]pentadeca-12(15),13-dien-9-yl]methyl-methylamino]methyl]benzamide
N-(2-aminophenyl)-4-[[[(8R,9R)-6-[(2S)-1-hydroxypropan-2-yl]-8-methyl-5-oxo-10-oxa-1,6,13,14-tetrazabicyclo[10.2.1]pentadeca-12(15),13-dien-9-yl]methyl-methylamino]methyl]benzamide
(1R)-N1-cyclopentyl-N2-(4-fluorophenyl)-1-(hydroxymethyl)-7-methoxy-9-methylspiro[1,3-dihydropyrido[3,4-b]indole-4,4-piperidine]-1,2-dicarboxamide
[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-decanoyloxypropan-2-yl] (Z)-tridec-9-enoate
2-amino-3-[[3-[(11Z,14Z)-henicosa-11,14-dienoyl]oxy-2-hydroxypropoxy]-hydroxyphosphoryl]oxypropanoic acid
(E)-2-[[(7Z,10Z,13Z,16Z,19Z)-docosa-7,10,13,16,19-pentaenoyl]amino]-3-hydroxydec-4-ene-1-sulfonic acid
(4E,8E,12E)-2-[[(7Z,10Z,13Z)-hexadeca-7,10,13-trienoyl]amino]-3-hydroxyhexadeca-4,8,12-triene-1-sulfonic acid
2-[[(4Z,7Z,10Z,13Z,16Z,19Z)-docosa-4,7,10,13,16,19-hexaenoyl]amino]-3-hydroxydecane-1-sulfonic acid
(E)-3-hydroxy-2-[[(5Z,8Z,11Z,14Z,17Z)-icosa-5,8,11,14,17-pentaenoyl]amino]dodec-4-ene-1-sulfonic acid
(4E,8E)-2-[[(4Z,7Z,10Z,13Z)-hexadeca-4,7,10,13-tetraenoyl]amino]-3-hydroxyhexadeca-4,8-diene-1-sulfonic acid
(4E,8E)-3-hydroxy-2-[[(8Z,11Z,14Z,17Z)-icosa-8,11,14,17-tetraenoyl]amino]dodeca-4,8-diene-1-sulfonic acid
(4E,8E,12E)-3-hydroxy-2-[[(9Z,12Z,15Z)-octadeca-9,12,15-trienoyl]amino]tetradeca-4,8,12-triene-1-sulfonic acid
(E)-3-hydroxy-2-[[(3Z,6Z,9Z,12Z,15Z)-octadeca-3,6,9,12,15-pentaenoyl]amino]tetradec-4-ene-1-sulfonic acid
(4E,8E)-3-hydroxy-2-[[(6Z,9Z,12Z,15Z)-octadeca-6,9,12,15-tetraenoyl]amino]tetradeca-4,8-diene-1-sulfonic acid
(6E)-14-hydroxy-4,14,16-trimethyl-8-methylidene-17-tridecyl-1-oxa-4,9,12-triazacycloheptadec-6-ene-2,5,10,13,15-pentone
4-[3-acetyloxy-2-[(8Z,11Z,14Z,17Z)-icosa-8,11,14,17-tetraenoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate
4-[3-butanoyloxy-2-[(6Z,9Z,12Z,15Z)-octadeca-6,9,12,15-tetraenoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate
4-[2-[(4Z,7Z,10Z,13Z)-hexadeca-4,7,10,13-tetraenoyl]oxy-3-hexanoyloxypropoxy]-2-(trimethylazaniumyl)butanoate
2-amino-3-[[3-butanoyloxy-2-[(9Z,12Z)-hexadeca-9,12-dienoyl]oxypropoxy]-hydroxyphosphoryl]oxypropanoic acid
[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-nonanoyloxypropan-2-yl] (Z)-tetradec-9-enoate
2-amino-3-[[2-[(9Z,12Z)-heptadeca-9,12-dienoyl]oxy-3-propanoyloxypropoxy]-hydroxyphosphoryl]oxypropanoic acid
[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-pentanoyloxypropan-2-yl] (Z)-octadec-9-enoate
3-[[3-acetyloxy-2-[(9Z,12Z)-octadeca-9,12-dienoyl]oxypropoxy]-hydroxyphosphoryl]oxy-2-aminopropanoic acid
[1-acetyloxy-3-[2-aminoethoxy(hydroxy)phosphoryl]oxypropan-2-yl] (Z)-henicos-11-enoate
[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-propanoyloxypropan-2-yl] (Z)-icos-11-enoate
[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-butanoyloxypropan-2-yl] (Z)-nonadec-9-enoate
[2-[(Z)-heptadec-9-enoyl]oxy-3-propanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate
[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-octanoyloxypropan-2-yl] (Z)-pentadec-9-enoate
[3-hexanoyloxy-2-[(Z)-tetradec-9-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate
[3-acetyloxy-2-[(Z)-octadec-9-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate
[3-heptanoyloxy-2-[(Z)-tridec-9-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate
[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-hexanoyloxypropan-2-yl] (Z)-heptadec-9-enoate
[2-[(Z)-pentadec-9-enoyl]oxy-3-pentanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate
[3-butanoyloxy-2-[(Z)-hexadec-9-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate
[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-heptanoyloxypropan-2-yl] (Z)-hexadec-9-enoate
4-[3-[(4E,7E)-deca-4,7-dienoyl]oxy-2-[(6E,9E)-dodeca-6,9-dienoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate
4-[2-[(E)-dec-4-enoyl]oxy-3-[(3E,6E,9E)-dodeca-3,6,9-trienoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate
4-[3-[(E)-dec-4-enoyl]oxy-2-[(3E,6E,9E)-dodeca-3,6,9-trienoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate
4-[2-[(4E,7E)-deca-4,7-dienoyl]oxy-3-[(6E,9E)-dodeca-6,9-dienoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate
1-Oleoyl-2-acetyl-sn-glycero-3-phosphocholine
A 1-oleoyl-2-acyl-sn-glycero-3-phosphocholine in which the acyl substituent at position 2 is specified as acetyl.
1-(9E-octadecenoyl)-2-acetyl-sn-glycero-3-phosphocholine
1-acetyl-2-(9Z-octadecenoyl)-sn-glycero-3-phosphocholine
MePC(19:1)
Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved
PE(23:1)
Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved
PAF(18:1)
Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved
Fesoterodine (L-mandelate)
Fesoterodine L-mandelate is an orally active, nonsubtype selective, competitive muscarinic receptor (mAChR) antagonist with pKi values of 8.0, 7.7, 7.4, 7.3, 7.5 for M1, M2, M3, M4, M5 receptors, respectively. Fesoterodine L-mandelate is used for the overactive bladder (OAB)[1][2].